Results 1 to 10 of about 466,117 (305)
Indian Journal of Endocrinology and Metabolism, 2015 Prashant Kaduskar, K M Suryanarayana
doaj +3 more sources
Pre-operative Endocrine Therapy [PDF]
Current Breast Cancer Reports, 2017 Pre-operative endocrine therapy can be used to down-stage large or locally advanced breast cancers in ER+ disease. In the last four decades, it has evolved from a treatment perceived as an alternative to surgery for those too unfit to undergo surgery or chemotherapy, to the present day where it is a valuable and valid option in the treatment of ...
Arthur, Laura M +3 more
openaire +3 more sources
Primary endocrine therapy of locally advanced breast cancer patients [PDF]
Archive of Oncology, 2003 Primary endocrine therapy has been traditionally reserved for elderly and unfit locally advanced breast cancer patients (LABC patients). In this group, the primary endocrine therapy could not be adequately compared to primary chemotherapy.
Nešković-Konstantinović Zora B.
doaj +1 more source
Frontiers in Oncology, 2021 PurposeTo evaluate the cost-effectiveness of adding ribociclib to endocrine therapy for pre/perimenopausal women with hormone receptor-positive (HR+), human epidermal receptor 2-negative (HER2-) advanced breast cancer from the US payer perspective ...
Eunae Jeong +4 more
doaj +1 more source
Frontiers in Oncology, 2022 PurposeThe purpose of this study was to evaluate endocrine therapy and chemotherapy for first-line, maintenance, and second-line treatment of hormone receptor-positive HER-2-negative metastatic breast cancer (HR+HER-2-MBC) and the relationship between ...
Qiuyue Liu +6 more
doaj +1 more source
Neoadjuvant endocrine therapy for luminal breast cancer treatment: a first-choice alternative in times of crisis such as the COVID-19 pandemic [PDF]
, 2020 The epidemiological emergency caused by CoV-2 (COVID-19) has changed priorities in breast cancer management. In those places where the pandemic has had the greatest effect, it is of paramount importance for most patients to be at home, reducing or ...
Martí, Covadonga +1 more
core +1 more source
Endocrine Toxicities of Antineoplastic Therapy [PDF]
Cancers, 2021 In recent years, the prognosis of many solid tumors has improved markedly thanks to new treatment strategies, including tyrosine kinase inhibitors (TKIs) and immunotherapy [...]
Puliani G., Appetecchia M.
openaire +3 more sources
Current Oncology, 2022 Omission of radiotherapy among older women taking 5 years of adjuvant endocrine therapy following breast conserving surgery for early-stage, hormone sensitive breast cancers is well-studied. However, endocrine therapy toxicities are significant, and many
Susan G. R. McDuff, Rachel C. Blitzblau
doaj +1 more source
Minnesota medicine, 2010 The link between ovarian hormones and breast cancer began to be formed as early as 1882 when TW Nunn observed the spontaneous regression of breast cancer in a woman 6 months after her menstruation ceased [1]. Oophorectomy was first proposed by the German clinician, Schinzinger, on the basis of his observation that younger women had more aggressive ...
Howell, Sacha J., Howell, Anthony
openaire +4 more sources